0001209191-19-048282.txt : 20190904 0001209191-19-048282.hdr.sgml : 20190904 20190904175915 ACCESSION NUMBER: 0001209191-19-048282 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190903 FILED AS OF DATE: 20190904 DATE AS OF CHANGE: 20190904 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dempsey James F. CENTRAL INDEX KEY: 0001637089 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37725 FILM NUMBER: 191075701 MAIL ADDRESS: STREET 1: C/O VIEWRAY INCORPORATED STREET 2: 2 THERMO FISHER WAY CITY: OAKWOOD VILLAGE STATE: OH ZIP: 44146 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ViewRay, Inc. CENTRAL INDEX KEY: 0001597313 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 421777485 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 THERMO FISHER WAY CITY: OAKWOOD VILLAGE STATE: OH ZIP: 44146 BUSINESS PHONE: 440-703-3210 MAIL ADDRESS: STREET 1: 2 THERMO FISHER WAY CITY: OAKWOOD VILLAGE STATE: OH ZIP: 44146 FORMER COMPANY: FORMER CONFORMED NAME: Mirax Corp DATE OF NAME CHANGE: 20140116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-09-03 0 0001597313 ViewRay, Inc. VRAY 0001637089 Dempsey James F. C/O VIEWRAY, INC. 2 THERMO FISHER WAY OAKWOOD VILLAGE OH 44146 1 1 0 0 Chief Scientific Officer Common Stock 2019-09-03 4 M 0 51460 0.68 A 272433 D Common Stock 2019-09-03 4 S 0 51460 3.566 D 220973 D Common Stock 2019-09-03 4 M 0 164697 0.68 A 385670 D Common Stock 2019-09-03 4 S 0 164697 3.566 D 220973 D Common Stock 2019-09-03 4 M 0 63257 0.70 A 284230 D Common Stock 2019-09-03 4 S 0 63257 3.566 D 220973 D Stock Option (right to buy) 0.68 2019-09-03 4 M 0 51460 0.00 D 2020-06-29 Common Stock 61752 0 D Stock Option (right to buy) 0.68 2019-09-03 4 M 0 164697 0.00 D 2020-06-29 Common Stock 197635 0 D Stock Option (right to buy) 0.70 2019-09-03 4 M 0 63257 0.00 D 2022-03-01 Common Stock 63257 0 D The transactions reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.42 to $3.94 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes 38,371 shares granted as Restricted Stock Units. As of the transaction date, none of the restricted stock units have vested. The shares subject to the option vested in 36 monthly installments beginning June 17, 2010 (the "Vesting Commencement Date") and became exercisable on each monthly anniversary thereafter, such that 100% of the shares subject to the option were fully vested on the 36 month anniversary of the Vesting Commencement Date. The shares subject to the option vested in 48 monthly installments beginning July 14, 2010 (the "Vesting Commencement Date") and became exercisable on each monthly anniversary thereafter, such that 100% of the shares subject to the option were fully vested on the 48 month anniversary of the Vesting Commencement Date. The shares subject to the option vested in 48 monthly installments beginning March 1, 2012 (the "Vesting Commencement Date") and became exercisable on each monthly anniversary thereafter, such that 100% of the shares subject to the option were fully vested on the 48 month anniversary of the Vesting Commencement Date. /s/ Robert McCormack, Attorney-in-Fact 2019-09-04